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ABSTRAK 
 
PENGENALAN: Pembedahan kanser pada tulang radius pergelangan tangan melibatkan 
pembedahan rumit mengeluarkan tulang dijangkiti dan rekonstruksi pengantian tulang 
yang hilang. Terdapat beberapa prosedur rekonstruktif telah digunakan termasuk graf 
fibular vascular dan bukan vaskular, osteoarticular allograft, penggantian sendi 
pergelangan tangan dan ulnar translokasi. Graf fibular proximal telah digunakan untuk 
mengekalkan fungsi pergelangan tangan yang lebih baik kerana persamaan dalam bentuk 
dan saiz hujung radius. Tujuan kajian ini adalah untuk menilai semula dan 
membandingkan hasil fungsi antara fusion pergelangan tangan dan rekonstruktif 
pergelangan tangan menggunakan graf fibular proksimal selepas pembedahan 
pembuangan luas tumor hujung radius dengan menggunakan sistem markah MSTS. 
 
KAEDAH: Kajian ini merupakan satu kajian keratan rentas di mana hanya satu intervensi 
dan penilaian dilakukan terhadap sebelas orang pesakit terpilih yang memenuhi kriteria-
kriteria inklusi dan exkluusi selepas pembedahan reseksi luas tumor hujung radius dan 
menggunakn graf fibular proksimal untuk membentuk semula pergelangan tangan. Semua 
pesakit termasuk dalam kajian ini adalah dari tahun 2000 hingga 2013 dan sampel kepada 
dua kumpulan, iaitu rekonstruktif pergelangan tangan dan fusion pergelangan tangan. 
Kebolehan fungsi dinilai dan dibandingkan dengan menggunakan sistem markah MSTS. 
Kekuatan gengaman tangan dan kadar penyatuan tulang dinilai oleh Jamar dinamometer 
tangan dan filem-filem radiograf masing-masing. 
 
KEPUTUSAN: Didapati 6 pesakit menjalani prosedur reconstruktif pergelangan tangan 
dan 5 pesakit menjalani fusion pergelangan tangan. Umur min pesakit ialah 36.55 tahun. 
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Min susulan tempoh adalah 6.3 tahun. Terdapat 9 kes gred II dan gred III GCT, 1 kes 
osteosarcoma dan 1 kes ABC dalam kajian ini. Pemjumlahan purata MSTS adalah dalam 
lingkungan 70% ke 93.3% dengan keputusan 4 baik dan 7 sangat baik. Min MSTS bagi 
kumpulan rekonstruktif pergelangan tangan adalah 24.83 (82.78%) dan fusion 
pergelangan tangan adalah 23.4 (78.0%). Purata kekuatan gengaman tangan berbanding 
dengan tangan sebelah yang normal adalah 60.0% bagi fusion pergelangan tangan di 
mana keputusannya lebih baik daripada rekonstruktif pergelangan tangan, iaitu 58.07%. 
Penyatuan tulang di bahagian radiofibular berlaku dalam 8 kes daripada 11 kes. Kadar 
penyatuan untuk rekonstruktif pergelangan tangan ialah 83.3% manakala bagi fusion 
pergelangan tangan adalah 60%. Pengecualian 3 kes yang gagal mencapai penyatuan, 
masa purata bagi cantuman adalah 18.4 minggu untuk rekonstruktif pergelangan tangan 
dan 18.7 minggu untuk fusion pergelangan tangan. Tiada kes ulangan tumor dan semua 
pesakit sekarang bebas daripada tumor. 
 
KESIMPULAN: Pembedahan graf fibular proksimal selepas reseksi luas tumor tulang 
hujung radius adalah baik ke sangat baik bagi markah MSTS untuk kedua-dua 
rekonstruktif dan fusion pergelangan tangan. Satu penemuan penting ialah skor untuk 
komponen sakit dalam MSTS lebih unggul dalam fusion pergelangan tangan. Walau 
bagaimanapun, di antara kedua-dua prosedur ini, tidak menghasilkan keputusan yang 
berbeza bagi jumlah MSTS skor. Komplikasi yang paling biasa yang dihadapi adalah 
subluxation di pergelangan tangan bagi kumpulan pembedahan rekonstruktif pergelangan 
tangan. 
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ABSTRACT 
 
INTRODUCTION : Distal radius bone tumour surgery is a complicated and challenging 
procedure which includes resection of the affected bone and reconstruction of the bony 
defect. Several reconstructive procedures have been described including vascularized and 
non-vascularized fibular graft, osteoarticular allograft, prosthetic replacement and ulnar 
translocation. The proximal fibular graft was used in order to preserve better wrist 
function due to its similarity in shape and size to the distal radius. The aim of this study is 
to evaluate and compare the functional outcome between total wrist fusion and wrist 
reconstruction with proximal fibular grafting after wide excision of distal radius tumour 
by using Musculoskeletal Tumor Society scoring system (MSTS). 
 
METHODS : This study was a cross-sectional, single intervention and retrospectively 
assessed the selected eleven patients with distal radius bone tumour who had wide 
excision and reconstructive surgery done with proximal fibular autograft that fulfilled the 
inclusion and exclusion criteria. All the patients recruited in this study were from year 
2000 to 2013 and sampled into two groups; the wrist reconstruction and total wrist fusion 
groups. Functional outcome was evaluated and compared by using Musculoskeletal 
Tumour Society scoring system (MSTS). Hand grip strength and union rate were assessed 
by Jamar hand dynamometer and plain radiographs respectively. 
 
RESULTS : There were 6 patients underwent wrist reconstruction procedure and 5 
patients underwent total wrist fusion. The mean age of patients was 36.55 years old. Mean 
follow up period was 6.3 years. There were 9 patients with Campanacci grade II to grade 
III giant cell tumours, 1 patient with osteosarcoma and 1 patient with aneurysmal bone 
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cyst in this study. Overall musculoskeletal tumor society (MSTS) score range from 70% 
to 93.3%, with 4 good and 7 excellent results. The mean MSTS score for wrist 
reconstruction group was 24.83 (82.78%) and total wrist fusion group was 23.4 (78.0%). 
Average grip strength compared to the contralateral hand was 60.0% for total wrist fusion 
which was better than wrist reconstruction, 58.07%. Radiofibular union occurred in 8 out 
of 11 cases. The union rate for wrist reconstruction was 83.3% whereas for total wrist 
fusion was 60%. Excluding the 3 non-union cases, average time for union was 18.4 weeks 
for the wrist reconstruction and 18.7 weeks for the total wrist fusion. There was no 
tumour recurrence and all the patients were disease free.  
 
CONCLUSION : Proximal fibular grafting after wide excision of distal radius bone 
tumour had good to excellent MSTS score for both wrist reconstruction and total wrist 
fusion. The only significant finding was the scoring for pain component in MSTS was 
more superior in total wrist fusion. However, there was no significant difference for the 
overall MSTS score between these procedures. The most commonly encountered 
complication was fibulocarpal subluxation which found in wrist reconstruction group. 
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Chapter 1: Introduction 
 
 Distal radius is not a common site for malignant or aggressive benign bone 
tumor. Surgical resection of distal radius tumour creates a massive bony defect and 
it warrants reconstruction in order to achieve functional painless wrist and good 
hand function. Few options,  including resection arthroplasty (Campanacci M. et al., 
1979), use of a non-vascularised (Aithal V.K. et al., 2003; Cheng C.Y. et al., 2001; 
Maruthainar N. et al., 2002) or vascularised autogenous fibular graft (Ferracini R. 
et al., 1999; Koichiro I. et al., 1999; Pho R.W., 1981) and allograft replacement 
(Kocher M.S. et al., 1998), prosthetic replacement (Gold A.M., 1965), ulnar 
translocation (Seradge H., 1982) and arthrodesis (Campbell C.J. et al., 1975; 
Vander Griend R.A. et al., 1993; Murray J.A. et al., 1986) have been used for 
reconstruction of this bone defect. Currently, custom megaprosthesis was also used 
to reconstruct the distal radius osseous defect. 
 
 In attempt to preserve better wrist function, the proximal fibular graft 
(vascularised or nonvascularised) is sometimes used for reconstruction due to its 
similarity in shape and size to the distal radius. Fibula reconstruction achieves good 
functional results with satisfying range of motion, but instability and degenerative 
change of carpofibular joint are frequently observed due to the relatively 
incongruence of carpofibular articular surfaces. Several authors have advocated 
arthrodesis rather than arthroplasty in view of high incidence of degenerative 
changes of carpofibular joint and carpal subluxation in later. 
  
 From the literature, only small number of published researches with small 
sample size or case reports found in related to the reconstruction procedure and 
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outcomes for distal radius bone tumour. The rationale behind this study is to assess 
and compare the functional performance in between total wrist fusion and wrist 
reconstruction and radiofibular union rate with proximal fibular graft after excision 
of distal radius tumour which involving a larger sample size especially in total wrist 
fusion group in which the outcome of this procedure was not commonly reported. 
The use of more rigid fixation with plate and screws especially in total wrist fusion 
may jeopardize the fibular graft and affect the union rate. We did assess the 
proximal union rate in between these two procedures. We also assessed grip 
strength of the operated hand and patients’ hand function by using Musculoskeletal 
Tumor Society scoring system (MSTS). Thus, we can predict the functional 
outcome and use it as a guide for us to counsel patient prior to surgical procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
Chapter 2: Literature Review 
2.1 Overview of bone tumour 
 Primary skeletal neoplasms account for 0.2% of human tumours, whereas 
involvement of skeletal tissue by metastatic disease is much more common. Bone 
tumours are neoplastic growth of tissues in the bone. They are rare and heterogeneous 
group of tumous. Abnormal growths found in the bone can be either benign or 
malignant. 
 
 In the past two decades, survival and the quality of life of patients with bone 
sarcomas has dramatically improved as a result of the multimodality treatment 
approach. Surgery, used in combination with chemotherapy and radiation therapy, can 
achieve cure in the majority of patients with bone sarcomas and resection is performed 
instead of amputation in more than 90% of all patients.  
 
2.1.1 Classification of bone tumour 
 Bone tumours may be classified as "primary tumours", which originate in bone 
or from bone-derived cells and tissues, and "secondary tumours" which originate in 
other sites and spread (metastasize) to the skeleton. Carcinomas of the prostate, breasts, 
lungs, thyroid, and kidneys are the carcinomas that most commonly metastasize to 
bone. Secondary malignant bone tumours are estimated to be 50 to 100 times as 
common as primary bone cancers. Because these lesions are so rare, not much 
pathologists have sufficient experience to deal comfortably with their diagnosis. This 
is further compounded by the steady evolution in the classification of bone tumours, 
which is based on their biological behaviours, ultrastructure and results of 
immunohistochemical and cytogenetic studies. 
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 Bone tumours are usually classified according to the type of matrix production 
for example osseous, cartilaginous, fibrous, cystic, giant cell, round cell and etc. 
Sarcomas originate primarily from elements of the mesodermal embryonic layer. 
Osteoid-producing sarcomas are classified as osteosarcomas and chondroid-producing 
sarcomas are classified as chondrosarcomas. The most common bone sarcomas are 
osteosarcoma, chondrosarcoma, and Ewing’s sarcoma. Common benign bone tumours 
are endochondroma, osteochondroma, nonossifying fibroma, chondroblastoma, 
osteoid osteoma, osteoblastoma, giant cell tumour, aneurysmal bone cyst and etc.  
 
Table 2.1 : Classification of primary bone tumours 
 
HISTOLOGIC TYPE BENIGN MALIGNANT 
Hematopoietic 
(41.1%) 
 Myeloma 
Lymphoma 
Chondrogenic 
(20.9%) 
Osteochondroma 
Chondroma 
Chondroblastoma 
Chondromyxoid fibroma 
Primary chondrosarcoma 
Secondary chandrosarcoma 
Dedifferentiated chondrosarcoma 
Mesenchymal chondrosarcoma 
Clear cell chondrosarcoma 
Osteogenic (19.3%) Osteoid osteoma 
Osteoblastoma 
Parosteal osteosarcoma 
Periosteal osteosarcoma 
Unknown Origin 
(9.8%) 
Giant cell tumour 
Fibrous histiocytoma 
Ewing’s sarcoma 
Malignant giant cell tumour 
Adamantinoma 
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Fibrogenic (3.8%) Fibroma 
Desmoplastic fibroma 
Fibrosarcoma 
Malignant fibrous histiocytoma 
Notochordal (3.1%)  Chordoma 
Vascular (1.6%) Hemangioma 
 
Hemangioendothelioma 
Hemangiopericytoma 
Lipogenic (<0.5%) Lipoma  
Neurogenic (<0.5%) Neurilemoma  
  
2.1.2 Biology behaviour of tumour 
 Tumours arising in bone tissues have characteristic patterns of biological 
behaviour because of their common mesenchymal origin and anatomical environment. 
These unique patterns form the basis of the staging system and current treatment 
strategies. Histologically, sarcomas are graded as low, intermediate or high 
grade. The grade is based on tumour morphology, extent of pleomorphism, atypia, 
mitosis, and necrosis. It represents its biological aggressiveness and correlates 
with the likelihood of metastases. 
 
 Sarcomas form a solid mass that grows centrifugally with the periphery of the 
lesion being the least mature. In contradistinction to the true capsule that surrounds 
benign lesions, which is composed of compressed normal cells; sarcomas are generally 
enclosed by a reactive zone or pseudocapsule. The thickness of the reactive zone 
varies with the histogenic type and grade of malignancy.  
 
 Sarcomas respect anatomical borders. Local anatomy influences tumour 
growth by setting natural barriers to extension. In a later stage the walls of that 
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compartment are violated (either the cortex of a bone or aponeurosis of a muscle), and 
the tumour breaks into a surrounding compartment. 
 
 The biology behaviour of certain benign bone tumours can be infrequent and 
unpredictable. Although numerous attempts have been made to predict the behaviour 
of GCT, there are no definite biologic or histologic parameters to determine the 
prognosis or aggressiveness of this lesion. Histological grading has proved to be of 
little value and since there is a great need for indicators of how aggressive the 
treatment should be in each particular tumour, different promising alternatives had 
been explored e.g. DNA cytophotometry and proliferation index, gene expression of 
vascular endothelial growth factor, in-vitro proliferation of neoplastic stromal cell 
population and etc. 
 
2.1.3 Etiology of bone tumour 
 Although bone tumour does not have a clearly defined cause, they often occur 
in areas of rapid bone growth. Researchers have identified several factors that increase 
the likelihood of developing these tumours.  
 
 The risk factors for bone sarcomas include previous radiation therapy, 
exposure to chemicals (e.g., vinyl chloride, arsenic), immunodeficiency, prior injury 
(scars, burns), chronic tissue irritation (foreign-body implants, lymphedema), 
neurofibromatosis, Paget’s disease, bone infarcts, and genetic cancer syndromes 
(hereditary retinoblastoma, Li–Fraumeni syndrome, Gardner’s syndrome).  
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 The incidence of bone tumours are also increased in families with familial 
cancer syndromes. The incidence of bone tumour in children is approximately 5 cases 
per million children each year. In most patients, however, no specific etiology can be 
identified. 
 
2.2 Evaluation of bone tumour 
2.2.1 Clinical Presentation 
 An adequate history and physical examination are the first and most important 
steps in evaluating a patient with a musculoskeletal tumour. Clinically, bone tumours 
may present in various ways. Patients may present to the orthopaedic oncologist with 
pain, a mass, or an abnormal radiographic finding detected during the evaluation of an 
unrelated problem. The more common benign lesions are frequently asymptomatic and 
are detected as incidental findings. Many tumours, however, produce pain or are 
noticed as a slow-growing mass. Sometimes, the first hint of a tumour’s presence is a 
sudden pathologic fracture. Radiographic analysis plays an important role in 
diagnosing these lesions.  
  
 Patients with bone tumours most frequently present with pain. The pain 
initially may be activity related, but a patient with a malignancy of bone often 
complains of progressive pain at rest and at night. Patients with benign bone 
tumours also may have activity-related pain if the lesion is large enough to weaken the 
bone.  
 
 Although some tumours show a sex predilection (e.g., female predominance 
with giant cell tumours), this is rarely of diagnostic significance. Race likewise is of 
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little significance, with the exception that Ewing sarcoma is exceedingly rare in 
individuals of African descent. Family history occasionally can be helpful, as in cases 
of multiple hereditary exostosis (autosomal dominant inheritance) and 
neurofibromatosis (autosomal dominant inheritance). Age may be the most important 
information obtained in the history because most benign and malignant 
musculoskeletal neoplasms occur within specific age ranges. 
 
2.2.2 Physical Examination 
 The physical examination should include evaluation of the patient’s general 
health and a careful examination of the part in question. A mass should be measured, 
and its location, shape, consistency, mobility, tenderness, local temperature and 
change with position should be noted. Atrophy of the surrounding musculature should 
be recorded, as should neurological deficits and adequacy of circulation. Cafe-au-lait 
spots or cutaneous hemangiomas also may provide diagnostic clues. Potential sites of 
lymph node metastases should be palpated. Although lymph node metastases are rare 
with most sarcomas, they often are present with rhabdomyosarcomas, epithelioid 
sarcomas, and synovial sarcomas. When metastatic disease is suspected the thyroid 
gland, lungs, abdomen, prostate and breast should be examined as appropriate. 
 
2.2.3 Radiography 
 Imaging studies play an important role in providing the exact location and 
extent of the tumour, detect features that help limit diagnostic possibilities and give 
clues to the aggressiveness of the tumour.  
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2.2.3.1     Plain radiograph  
 Plain radiographs remain the key imaging modality in the evaluation of bone 
tumours. Based on medical history, physical examination and plain radiographs, 
accurate diagnosis of bone tumours can be made in more than 80% of cases. Because 
of the fine trabecular detail revealed by plain radiographs, bone lesions of the 
extremities can be detected at a very early stage. Whereas lesions of the spine and 
pelvis are not diagnosed until a large volume of bone has been destroyed. 
 
2.2.3.2     Computerized tomography ( CT ) scan 
 Computerized tomography (CT) scan should be performed on a helical scanner 
that enables improved two-dimensional images and three dimensional reconstruction 
capability. The field of view should be small enough to allow adequate resolution, 
particularly of the lesion and the adjacent neurovascular bundle and muscle groups. 
The slice thickness should be designed in order to allow at least 10–15 slices through 
the tumour. Intravenous contrast dye is of little value in the evaluation of bone 
tumours. Once a bone lesion is found on plain radiograph, CT scan is the imaging 
modality of choice to evaluate the extent of bone destruction. 
 
2.2.3.3     Magnetic resonance imaging ( MRI ) 
 MRI is a valuable tool in the evaluation of the medullary and soft-tissue 
components of bone tumours. The signal intensity of a tumour is assessed by 
comparing it with that of the adjacent soft tissues, specifically skeletal muscle and 
subcutaneous fat. MRI also enables one to view a lesion in all three planes (axial, 
sagittal, and coronal). Contrast- enhanced MRI is useful in evaluating the relationship 
of a tumour to the adjacent blood vessels and in characterizing cystic lesions. MRI has 
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been proven to be superior to CT in the evaluation of the intramedullary and 
extraosseous, extent of bone tumours. The general guidelines regarding narrowing of 
the field and recommended number of slices per tumour are similar to those of CT 
scan. 
 
2.2.4 Biopsy 
 Biopsy is a key step in the diagnosis of a musculoskeletal tumour. In a book 
published in 1958, Jaffe stated that a biopsy should be regarded as the final diagnostic 
procedure, not as a mere short cut to diagnosis (Jaffe H. L., 1958). Biopsy must be 
preceded by careful clinical evaluation and analysis of the imaging studies. 
 
  In the past, biopsies were performed routinely through a large incision with 
significant contamination of the surrounding soft tissues with tumour cells. The 
contamination however had minimal significance because most malignant tumours of 
the extremities and pelvis were treated with amputation. Today, limb sparing 
procedures are performed in 90–95% of patients with musculoskeletal tumours of the 
extremities, and indications and surgical technique of musculoskeletal biopsy had to 
be changed to allow these procedures to be performed (Chang A. E., Sondak V. K., 
1995; Simon M. A. 1982)   
 
 The position of the biopsy site within the lesion has a major significance 
because bone tumours may have regional morphologic variations (Enneking W. F., 
1983; Dorfman H. D. et al., 1988; Chang A. E. et al., 1995). As a result of that 
heterogeneity, multiple samples are required to establish a diagnosis. The biopsy 
incision or the needle puncture hole, and the tract to the tumour, must be made with 
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the planned surgical incision site so that they will be included within the surgical 
specimen. Preferably, the surgeon performing the biopsy will be the same person who 
will perform the definitive procedure. 
 
 Open incisional biopsy is a reliable diagnostic method because it allows the 
pathologist to evaluate cellular morphologic features and tissue architecture from 
different sites of the lesion.  
 
 Needle biopsy of mesenchymal tumours was criticized because the quantity of 
biopsy material was often insufficient for routine histopathologic evaluation and 
ancillary studies that require tissue. It has been shown to be a reliable technique only 
for the diagnosis of soft-tissue tumours when the cell type of the tumour is 
homogeneous. 
 
 Core needle biopsy (CNB) provides a core of tissue with a maximum length 
of 20 mm, was shown to be more than 90% accurate in differentiating malignant from 
benign lesions (Heslin M. J. et al., 1997). In most patients with suspected bone 
sarcomas it is the biopsy performed before initiation of treatment. It should be 
performed under CT or fluoroscopy guidance, and multiple cores should be obtained. 
 
 Open biopsy is performed when the pathologic diagnosis either is inconclusive 
or does not correlate with the clinical presentation and radiologic findings.  
 
 Poorly performed biopsy remains a common issue in patients with 
musculoskeletal tumours who are referred to orthopaedics oncology centers. An 
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inadequately performed biopsy may fail to allow proper diagnosis, have a negative 
impact on survival and ultimately necessitate an amputation to accomplish adequate 
margins of resection. 
 
2.3 Staging of bone tumours 
 Staging is the process of classifying a tumour with respect to its degree of 
differentiation, as well as its local and distant extent, in order to plan the treatment and 
estimate the prognosis. Staging allows the surgeon to determine the type and the extent 
of the operation that is necessary for a specific type of tumour in a particular 
anatomical location, as well as the indication for neoadjuvant treatment modalities. 
Staging of a musculoskeletal tumour is based on the findings of the physical 
examination and the results of imaging studies. Biopsy and histopathological 
evaluation are essential components of staging, but should always be the final step. 
(Barry Schmookler et al., 2001) 
 The Musculoskeletal Tumour Society adopted staging systems that were 
originally described by Enneking et al. (Enneking W. F. et al., 1980; Enneking W. F., 
1983), for benign and malignant bone tumours, and the American Joint Committee on 
Cancer developed, with few changes, a staging system for malignant bone tumours 
(Fleming I. D. et al., 1997).  
 Enneking staging system of benign tumours are designated by Arabic numbers, 
and malignant tumours are designated by Roman numerals. Enneking’s staging system 
is based on three factors: histological grade (G), site (T) and the presence or absence 
of metastases (M). The anatomical site (T) may be either intracompartmental (A) or 
extracompartmental (B). This information is obtained preoperatively on the basis of 
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the data gained from the various imaging modalities. A tumour is classified as 
intracompartmental if it is bounded by natural barriers to extension such as bone, 
fascia, synovial tissue, periosteum or cartilage. An extracompartmental tumour may be 
either a tumour that violated the borders of the compartment from which it originated, 
or a tumour that originated and remained in the extracompartmental space. A tumour 
is assigned to stage III (M1) if a metastasis is present at a distant site or in a regional 
lymph node.  
 Enneking also described a staging system of benign bone tumours, which 
remains the one that is most commonly used (Enneking W. F., 1983) (Table 2.2). This 
system is based on the biological behaviour of the tumours as suggested by their 
clinical manifestation and radiological findings. Benign bone tumours grow in a 
centrifugal fashion and a rim of reactive bone is typically formed as a response of the 
host bone to the tumour. The extent of that reactive rim reflects the rate at which the 
tumour is growing. It is usually thick and well-defined around slowly growing 
tumours, and barely detectable around fast-growing, aggressive tumours. 
 Latent benign bone tumours are classified as stage 1. Such tumours are 
usually asymptomatic and are commonly discovered as an incidental radiographic 
finding. The natural history is it grows slowly during normal growth of the individual 
and then to stop, and in most cases it heals spontaneously. These lesions usually heal 
following simple curettage.  
 Active benign bone tumours are classified as stage 2 lesions. These tumours 
grow progressively but do not violate natural barriers. Associated symptoms may 
occur. Curettage and burr drilling are curative in most cases.   
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 Aggressive benign bone tumours are classified as stage 3. It may cause 
destruction of surrounding bone and usually break through the cortex into the 
surrounding soft tissues. Local control can be achieved only by curettage and 
meticulous burr drilling with a local adjuvant such as liquid nitrogen or by resection of 
the lesion with a margin of normal tissue (i.e., wide resection).  
Table 2.2 : Enneking’s System for Staging Benign and Malignant Bone Tumours 
Enneking’s System for Staging Benign and Malignant Bone Tumours 
BENIGN 
1. Latent—low biological activity, remains static or heals spontaneously. Well 
marginated; often incidental findings.      (i.e., nonossifying fibroma) 
2. Active—Progressive growth, limited by natural barriers. Symptomatic, limited 
bone destruction may present with pathological fracture       (i.e., aneurysmal bone 
cyst) 
3. Aggressive— Progressive growth, invasive, not limited by natural barriers. Bone 
destruction/soft tissue extension; do not respect natural barriers       (i.e., giant cell 
tumour)  
MALIGNANT 
STAGE                GRADE                   SITE                         METASTASES 
IA                          Low                 Intracompartmental            None 
IB                          Low                 Extracompartmental           None 
IIA                        High                 Intracompartmental            None 
IIB                        High                 Extracompartmental           None 
III                         Any                  Any                                     Regional or distant 
                                                                                                  metastases 
 Alternatively, many orthopaedic oncologists stage musculoskeletal 
malignancies according to the American Joint Committee on Cancer (AJCC) system 
(Fleming I. D. et al., 1997). The AJCC staging system for bone sarcomas is based on 
tumour grade, size, and presence and location of metastases. Stage I tumours, which 
are low grade; and stage II tumours, which are high grade, are subdivided based on 
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tumour size. Stage I-A and II-A tumours are 8 cm or less in their greatest linear 
measurement; stage I-B and II-B tumours are larger than 8 cm. Stage III tumours have 
―skip metastases,‖ which are defined as discontinuous lesions within the same bone. 
Stage IV-A involves pulmonary metastases, whereas stage IV-B involves non-
pulmonary metastases.  
Table 2.3 : American Joint Committee on Cancer System for Staging Bone Sarcomas 
American Joint Committee on Cancer System for Staging Bone Sarcomas 
STAGE                   GRADE                   SIZE                    METASTASES 
I-A                           Low                         ≤8 cm                     None 
I-B                           Low                         >8 cm                     None 
II-A                         High                         ≤8 cm                     None 
II-B                         High                         >8 cm                     None 
III                            Any                          Any                        Skip metastasis 
IV-A                       Any                           Any                       Pulmonary metastases 
IV-B                        Any                          Any                        Nonpulmonary metastases 
 However for giant cell tumour (GCT), besides Enneking’s grading system for 
benign bone tumour, Campanacci (Campanacci M. et al., 1987) had also designed a 
staging system based on radiological appearance of cortical involvement. 
Stage 1 : Intraosseous lesion. Radiographically well-circumscribed lucent lesion with 
no aggressive features (eg, periosteal reaction, soft-tissue mass, cortical breach). 
Stage 2 : Intraosseous lesion with cortical thinning. Relatively well-defined 
radiographic borders without a radiopaque rim  
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Stage 3 : Extraosseous lesion. Indistinct or ill-defined borders with radiographic 
demonstration of cortical bone destruction, and a soft-tissue mass. 
 A high grade tumour and evidence of tumour metastasis are associated with 
poor prognosis for all malignant bone tumours regardless of the staging system that is 
used. 
2.4 Overview management of bone tumour 
 The management of bone tumours has made vast strides in the last few decades. 
The advent of better imaging modalities, more effective chemotherapy, improved 
radiotherapy techniques, a better understanding of anatomy with continuous 
refinement in surgical techniques and advances in prosthesis design and materials have 
all played a part in increasing the incidence of limb salvage surgery. Limb salvage 
surgery includes all of the surgical procedures designed to accomplish removal of a 
tumour and reconstruction of the limb with an acceptable oncologic, functional and 
cosmetic result. From an era where amputation was the only option, the current day 
function preserving resections and complex reconstructions have been a major 
advance. 
 Though the number of limb salvage surgeries undertaken for malignant bone 
tumours of the extremity has increased, the principles that govern surgical resection of 
bone tumours remain unchanged. Tumour recurrence, metastasis and a generally 
dismal prognosis were a powerful deterrent to progress in limb salvage treatment.   
2.4.1 Types of surgical resections  
 There are four basic types of excisions, each is based on the relationship of the 
dissection plane to the tumour and its pseudocapsule. 
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i. An intralesional excision is performed within the tumour mass and results in 
removal of only a portion of it, the pseudocapsule and macroscopic tumour are left 
behind.  
ii. In a marginal excision, the dissection plane passes through the pseudocapsule of 
the tumour. Such a resection may leave microscopic disease.  
iii. Wide (en-bloc) excision entails removal of the tumour, its pseudocapsule, and a 
cuff of normal tissue peripheral to the tumour in all directions. This is the desired 
margin for sarcoma resection, however the adequate thickness of the normal tissue 
cuff is a matter of controversy. For bone sarcomas, it is generally believed to be a few 
centimetres. 
iv. Radical excision involves removal of the tumour and the entire anatomical 
compartment within which it is located (Figure 2.1). This excision can achieve a 
marginal or a wide margin, depending on how close the tumour is to the border of the 
compartment. However, radical excision excludes the possibility of skip metastases. 
 Depending on the pathology and aggressiveness of the lesion, it is important to 
plan a surgical procedure capable of obtaining the desired margins for local control. A 
benign giant cell tumour can be adequately managed with an intralesional procedure 
whereas an aggressive giant cell tumour would require a wide excision in order to gain 
adequate local disease clearance. 
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Figure 2.1 : Various excision types for bone tumour (Musculoskeletal Cancer Surgery, 
2001) 
 Any of these excision types may be accomplished by a limb-salvage procedure 
or by amputation. An amputation is not necessarily an adequate cancer operation, but 
it is a method of achieving a specific margin. It may entail a marginal, wide or radical 
excision, depending upon the plane in which it passes. Staging studies are used to 
assess local tumour extent and relevant local anatomy, and thereby determine how a 
desired surgical margin may be achieved. 
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2.5 Overview of distal radius tumours 
2.5.1 Giant cell tumour ( GCT ) 
 Giant cell tumors of bone are benign lesions that can be locally aggressive. It is 
a type of giant cell-rich lesion of bone. This benign mesenchymal tumor has 
characteristic multinuclear giant cells. Mononuclear stromal cells are the 
physiologically active and diagnostic cell type. Most GCTs are located in the 
epiphyseal regions of long bones. Although the distal radius is an untypical location, 
about 10 percent of all giant cell tumour (GCT) affects this part of the skeleton 
(Campanacci M. et al., 1987; Dahlin D.C. et al., 1970; Goldenberg R.R. et al., 1970; 
Eckardt J. J. et al., 1986; McDonald D. J. et al., 1986). It represents the third most 
common location after the distal part of the femur and the proximal part of the tibia 
(Campanacci M. et al., 1987).  
 These tumors are typically treated with local resection and/or curettage. 
Radiation therapy is selectively used for tumors in difficult to resect locations (i.e. 
spine). Intralesional curettage with or without adjuvant therapy (eg. phenol, bone graft 
or polymethylmethacrylate ) is the procedure of choice for less aggressive lesions over 
distal radius without marked bone or joint destruction (Apichat A. et al., 2009). There 
is a high rate of local recurrence after most methods of local treatment for aggressive 
benign bone tumour. Therefore wide resection of the tumour and reconstruction in this 
location might be necessary in aggressive cases which exhibit extraosseous extension 
or recurrence after previous treatment. 
 Metastatic spread to the lungs is rare, about 2 to 5%. Risk factors for lung 
metastasis include local recurrence, the location of the primary giant cell tumor (distal 
radius, proximal femur, and sacrum), Stage 3 GCT and an immunocompromised state. 
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The clinical course is marked by indolence in character in which some are self-
limiting in nature while others may have spontaneous regression but about 25% can 
caused death by pulmonary failure (Rock M.G.,1984 ; Kay R.M. et al., 1994). 
Therefore, early detection is important with plain x-ray of primary site and chest, CT-
thorax and bone scan. These imaging studies are repeated during follow-up for further 
evaluation. 
2.5.2 Osteosarcoma 
 Osteosarcoma, the most common bone sarcoma, affects children and 
adolescents. It is a mesenchymally derived, high-grade bone sarcoma. The incidence 
of new diagnoses peaks in the second decade of life. Twenty percent of patients 
present with clinically detectable metastases, with micrometastases presumed to be 
present in many of the remaining patients.   
 The most frequent sites of origin are the distal femur, proximal tibia and 
proximal humerus. Patients typically present with pain, swelling, localized 
enlargement of the extremity and, occasionally, pathologic fracture. Most patients 
present with localized disease. Radiographs commonly demonstrate a mixed sclerotic 
and lytic lesion arising in the metaphyseal region of the involved bone. Computed 
tomography and bone scanning are recommended to detect pulmonary and bone 
metastases, respectively. 
 The wrist is uncommon sites for osteosarcomas. Less than 1% of 
osteosarcomas arise in the distal radius (KK Unni, 1996). Patients with wrist 
osteosarcomas are older than those with osteosarcomas in other sites and have a better 
prognosis (K Okada et al., 1993). 
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 The treatment of osteosarcoma requires a multidisciplinary approach involving 
the family physician, orthopedic oncologist, medical oncologist, radiologist and 
pathologist. Before 1970, osteosarcomas were treated with amputation. Survival was 
poor: 80 percent of patients died from metastatic disease. With the development of 
induction and adjuvant chemotherapy protocols, advances in surgical techniques and 
improvements in radiologic staging studies, 90-95 percent of patients with 
osteosarcoma can now be treated with limb-sparing resection and reconstruction.  
 Limb-salvage procedures with wide surgical margins are the mainstay of 
surgical intervention. A combination of advances in surgical technique, improved 
imaging modalities to accurately document tumor extent, and the effect of neoadjuvant 
chemotherapy has made limb salvage procedures a safe alternative to amputation. 
Adjuvant chemotherapy plays an essential role in the control of subclinical metastatic 
disease. In some patients for whom complete surgical excision is impossible, the 
addition of radiation therapy may allow local tumor control. 
 Advances in chemotherapy protocols have led to a 5-year survival rate of 60% 
to 78%. The most effective chemotherapy agents currently in use include high-dose 
methotrexate, doxorubicin, cisplatin, and ifosfamide/etoposide. Among the goals of 
future treatment regimens are improved chemotherapeutic agents with higher 
specificity and lower toxicity. 
2.5.3 Ewing’s sarcoma 
 Ewing’s sarcoma is a primitive malignant bone tumour consisting of small, 
blue, round malignant cells that may show varying degrees of neural differentiation. It 
accounts for approximately 5% of all malignant bone tumours. Ewing sarcoma of bone 
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represents the second most common primary malignant tumor of bone in children and 
adolescents, exceeded in prevalence only by osteosarcoma. It is the fourth most 
common primary bone tumour following myeloma, osteosarcoma and 
chondrosarcoma. It is rare in patients younger than 5 or older than 30 and the highest 
frequency of this malignancy occurs in patients between 10 and 15 years old. Ewing’s 
sarcoma is more frequent in males than females (3:2) and is rare in Blacks and Asians. 
 There is a wide skeletal distribution for Ewing sarcoma. The long bones and 
the pelvis are most commonly affected. The femur is affected in 20-27% of tumours, 
the tibia and fibula in 15-23% and the humerus in 8-11%. Lesions are classically 
located in the diaphysis of long bones but can be metaphyseal-epiphyseal with almost 
equal frequency. The pelvic girdle accounts for 20-26% of the tumours and the ribs 7-
11%. Any portion of any bone can be affected but hand or foot (3-6%), radius or ulna 
(3-5%), skull (1%) or sternum (0.2%) is rarely reported. 
 Modern combined modality therapies with multiagent chemotherapy have 
given a significant improvement in the prognosis of Ewing’s sarcoma of bone (5-year 
survival rates have increased from 10-15% to 65-70% in the last 40 years). However, 
lesser improvements have been seen for patients with metastatic or recurrent disease 
with a 5-year survival rate of less than 10-35%. Small, distal extremity lesions have a 
good prognosis, whereas patients with metastatic disease at presentation, large lesions, 
proximal or axial lesions or recurrent disease have a less favourable prognosis. 
 The treatment of Ewing’s sarcoma of bone is currently based on combined 
therapy with neoadjuvant chemotherapy, radiation therapy and surgical resection of 
the primary tumour. Due to the complexity of treatment, it is mandatory for the 
members of the multidisciplinary team (oncologists, surgeons, radiation oncologists as 
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well as pathologists and radiologists) to cooperate closely to customize treatments to 
the histologic response and tumour volume and site, in order to offer the best treatment 
for each patient. Neoadjuvant chemotherapy is effective for shrinking the primary 
tumour and management of potential metastatic disease. Standard therapy for localized 
Ewing’s sarcoma includes preoperative induction chemotherapy (4-5 cycles) and local 
treatment with surgery and/or radiotherapy. 
. The role of surgery for local control has gained importance. Surgical resection 
with adequate margins remains one of the most important prognostic factors for 
Ewing’s sarcoma. The role of surgery and radiation for local disease is still 
controversial but surgery gives better disease free survival (DFS) than radiotherapy 
alone. Early results from the EICESS92 study show that significantly better DFS and 
overall survival (OS) occur with multimodality treatment, i.e. a combination of 
chemotherapy, surgery and radiotherapy. (Paulussen M. et al., 2008)  
 Many centres advocate resection of the lesion after neoadjuvant chemotherapy, 
and radiation for positive or inadequate surgical margins. Currently, limb salvage 
surgery is recommended whenever possible.  
 Lesions arising in the pelvis or centrally located (sacrum, spine) remain 
surgically challenging and should be carefully evaluated by the multidisciplinary team: 
radiotherapy may be the best choice for large volume axial bone tumours or 
unresectable lesions, in order to avoid unacceptable mutilating surgery.  
 Metastases are predominantly haematogenous. The lung is the most common 
site of metastasis, followed by bone and bone marrow. The incidence of metastatic 
disease at the time of diagnosis ranges from 15% to 35%. The risk of distant 
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metastasis with a localized tumour is around 40-50%. Metastasis to regional or distal 
lymph nodes is unusual. 
2.6 Overview of surgical treatment of wrist bone tumours 
 The wrist is uncommon area for bone tumours. Large series of limb salvage 
procedures in these areas are available. In general, benign bone tumours are 
adequately treated by either an intralesional procedure (eg. curettage and burr drilling, 
cryosurgery) or by marginal excision. For aggressive benign bone tumours or 
recurrence cases, wide resection of tumour and reconstruction, with or without 
medical therapy (eg. Bisphosphonate or Denosumab) is the treatment option. Primary 
bone sarcomas, multidisciplinary treatment with wide surgical resection and 
reconstruction, radiation and/or chemotherapy is used to maximize local and systemic 
control. Metastatic tumour are treated according to the general intent of the surgery. 
When a palliative surgery is performed, metastatic lesions are treated by an 
intralesional procedure. If a curative procedure is performed, as in the case of solitary 
breast metastasis, for example, the lesion is treated as if it was a primary bone sarcoma 
(ie, wide excision). 
2.6.1 Distal radius anatomy 
 The wrist is a complex joint that bridges the hand to the forearm. It is actually 
a collection of multiple bones and joints. The bones comprising the wrist include the 
distal ends of the radius and ulna, 8 carpal bones, and the proximal portions of the 5 
metacarpal bones. 
 All of these bones participate in complex articulations that allow variable 
mobility of the hand. Relative to the forearm, the hand is capable of 3 degrees of 
